Next Generation News and Research

RSS

UK cancer patients use Brainlab Mixed Reality Viewer to visualize, understand their treatment

For the first time, patients in the UK will have access to Brainlab Mixed Reality Viewer as part of their cancer treatment; a new way for physicians to provide visualization of treatment to their patients, actively involving them in their own cancer care.

13 Feb 2020

Maternal use of cosmetics containing parabens tied to child's future overweight

Parabens are used as preservatives in cosmetics. If pregnant women use cosmetics containing parabens that remain on the skin for protracted periods, this may have consequences for their child's subsequent weight development.

13 Feb 2020

Skin cancer rates found to be higher among gay and bisexual men

In the largest study of skin cancer rates among gay, lesbian or bisexual individuals, investigators from Brigham and Women's Hospital report important differences in skin cancer prevalence among sexual minorities. Rates of skin cancer were higher among gay and bisexual men compared to heterosexual men but lower among bisexual women than heterosexual women.

12 Feb 2020

Bayer and Meiogenix join forces to advance agricultural research and development

Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix's proprietary technologies related to plant breeding and genome editing applications.

From Bayer AG 10 Feb 2020

Next generation phospholipid removal microplate

Porvair Sciences announce Microlute PLR - a new benchmark product for phospholipid removal. The 96-well microplate provides effective removal (>99%) of phospholipids and proteins with higher levels of reproducibility from plasma and serum samples while maintaining maximum recovery of target analytes.

From Porvair Sciences Limited 6 Feb 2020

Research shows new ways to curb the development anti-cancer therapy resistance

Research by Professor Yuval Shaked of the Technion - Israel Institute of Technology presents new ways to curb the development anti-cancer therapy resistance, a phenomenon that is detrimental to the efficacy of existing cancer treatments.

5 Feb 2020

Analysis shows overall survival in lung cancer patients harboring 'niche' mutations

Mutations were observed in all genes studied, except c-MET, DDR2, MAP2K1, and RET.

5 Feb 2020

Gut microbes in wasps help overcome pesticides

An intriguing study published in February 2020 in the journal Cell Host & Microbe reports that when wasps are exposed to atrazine, a commonly used pesticide, the gut microbiome undergoes changes that help them overcome the ill-effects of the exposure. In addition, the changes are passed on to the offspring, which means that the next generation will also inherit atrazine resistance even without being exposed to the chemical.

4 Feb 2020

New technology provides point of care insights to Rush oncologists

Rush University Medical Center is the first health care organization to launch medical record company Epic's module for genomic results, giving providers the tools they need to tailor patient care at the molecular level.

4 Feb 2020

Indivumed and Biognosys partnership aims to enhance proteomics insights

Indivumed, a physician-led, integrated global oncology solution provider, announced its partnership with Biognosys.

From Biognosys 4 Feb 2020

Sperm microbiome revealed with RNA sequencing

A new study reports the first-ever detailed description of the human sperm microbiome, using newer RNA sequencing techniques that are capable of discriminating between sperm RNA and that of bacterial contamination or colonization.

2 Feb 2020

New study lays foundation for next generation aortic grafts

A new study by researchers at McGill University has measured the dynamic physical properties of the human aorta, laying the foundation for the development of grafts capable of mimicking the native behaviour of the human body's largest artery.

30 Jan 2020

Highly active adults engage in a greater variety of activities to meet exercise guidelines

Highly active adults engage in a greater variety of physical activities than do less active adults, finds a new study led by researchers at NYU Rory Meyers College of Nursing.

29 Jan 2020

Porvair Sciences offers next generation microplate for phospholipid removal

Porvair Sciences announce Microluteä PLR - a new benchmark product for phospholipid removal. The 96-well microplate provides effective removal (>99%) of phospholipids and proteins with higher levels of reproducibility from plasma and serum samples while maintaining maximum recovery of target analytes.

From Chromatrap® - Porvair Sciences Ltd 29 Jan 2020

Study could lead to next-generation clinical testing for hidden hearing loss

A pair of biomarkers of brain function -- one that represents "listening effort," and another that measures ability to process rapid changes in frequencies -- may help to explain why a person with normal hearing may struggle to follow conversations in noisy environments, according to a new study led by Massachusetts Eye and Ear researchers.

28 Jan 2020

Parkinson's Foundation announces first-ever Physical Therapy Faculty Award

The Parkinson's Foundation announced that it has awarded its first-ever Parkinson's Foundation Physical Therapy Faculty Award to three physical therapists, totaling $30,000.

28 Jan 2020

NYU study provides better understanding of youth vaping patterns

While youth vaping rates have increased in recent years, most middle and high school students don't vape or smoke and very few vape or smoke daily, finds a study led by researchers at NYU School of Global Public Health.

27 Jan 2020

Meridian launches High-Specificity Pfu HS Mix to increase customers’ testing capabilities

Meridian Bioscience, Inc. today announced the launch of a High-Specificity Pfu HS Mix that not only provides high-fidelity amplification, but also offers market-leading amplification for companion diagnostic (CDx) and clinical testing.

From Meridian Bioscience, Inc. 24 Jan 2020

RB1 alterations in cancer cells may lead to treatment resistance

The Cancer Genetics Group of the Josep Carreras Leukaemia Research Institute, led by Montse Sánchez-Céspedes, together with Luis Montuenga from CIMA, and Enriqueta Felip from Vall d'Hebron Hospital, has revealed that inactivation of RB1 through intragenic rearrangements is frequent in lung cancer cells from non-smoking patients with EGFR mutations.

24 Jan 2020

Transcriptional scanning in the sperm may regulate rate of human evolution

Maturing sperm cells turn on most of their genes, not to follow their genetic instructions like normal, but instead to repair DNA before passing it to the next generation, a new study finds.

23 Jan 2020